Dorman Products holder plans sale of 734 shares

Dorman Products, Inc. filed a notice of proposed sale of 734 shares of common stock of DORM through Fidelity Brokerage Services LLC on NASDAQ, with an indicated value of $99,244.14.

Rhea-AI Filing Summary

Dorman Products, Inc. filed a notice of proposed sale of 734 shares of common stock of DORM through Fidelity Brokerage Services LLC on NASDAQ, with an indicated value of $99,244.14. The filing also lists upcoming issuances from restricted stock vesting awards of 496 shares on February 28, 2025 and 238 shares on March 4, 2025 as compensation-related stock. The section covering securities sold during the past three months does not list any transactions.

Key Figures

Shares proposed to be sold: 734 shares Indicated value of proposed sale: $99,244.14 CUSIP or identifier: 29675618 +3 more

6 metrics

Shares proposed to be sold 734 shares Common stock in Form 144 securities information

Indicated value of proposed sale $99,244.14 Value associated with 734 common shares to be sold

CUSIP or identifier 29675618 Identifier listed with the common stock to be sold

Proposed sale date or related date 08/17/2026 Date associated with the NASDAQ-listed common shares

Restricted stock vesting tranche 1 496 shares Common shares vesting on 02/28/2025 as Compensation

Restricted stock vesting tranche 2 238 shares Common shares vesting on 03/04/2025 as Compensation

Key Terms

Form 144, Restricted Stock Vesting, Compensation, Securities To Be Sold, +1 more

5 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 02/28/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"496 | 02/28/2025 | Compensation Common | 03/04/2025"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for DORM in this Form 144 filing?

The notice covers a proposed sale of 734 shares of Dorman Products, Inc. common stock through Fidelity Brokerage Services LLC on NASDAQ, with an indicated value of $99,244.14, as reported in the Form 144 securities information section.

What is the approximate value of the DORM shares proposed to be sold?

The proposed sale involves Dorman Products, Inc. common stock valued at about $99,244.14. This value is tied to the 734 shares listed in the securities information section of the Form 144 for trading on NASDAQ.

Which broker is handling the proposed DORM stock sale?

The proposed sale of 734 Dorman Products, Inc. common shares is listed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, with the shares indicated for trading on NASDAQ.

What future restricted stock vesting is disclosed for DORM?

The filing lists restricted stock vesting awards of 496 common shares scheduled for February 28, 2025 and 238 common shares scheduled for March 4, 2025, both labeled as Compensation and issued by the company.

Does the Form 144 show any DORM securities sold in the past three months?

The section labeled "Securities Sold During The Past 3 Months" does not list any specific Dorman Products, Inc. transactions, indicating no detailed prior three-month sales are reported within this notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 11:59 AM Accepted by SEC EDGAR 08/17/2026 - 11:58 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001931700
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Dorman Products, Inc.
SEC File Number	000-18914
Address of Issuer	3400 E WALNUT ST COLMAR PENNSYLVANIA 18915
Phone	2159971800
Name of Person for Whose Account the Securities are To Be Sold	Long Donna M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	734	99244.14	29675618	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2025	Restricted Stock Vesting	Issuer			496	02/28/2025	Compensation
Common	03/04/2025	Restricted Stock Vesting	Issuer			238	03/04/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Donna Long
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)